Grzegorz Satała Selected Research

serotonin 6 receptor

10/2021	The Phenoxyalkyltriazine Antagonists for 5-HT6 Receptor with Promising Procognitive and Pharmacokinetic Properties In Vivo in Search for a Novel Therapeutic Approach to Dementia Diseases.
10/2021	Neuropathic pain-alleviating activity of novel 5-HT6 receptor inverse agonists derived from 2-aryl-1H-pyrrole-3-carboxamide.
1/2021	Structure-Based Design and Optimization of FPPQ, a Dual-Acting 5-HT3 and 5-HT6 Receptor Antagonist with Antipsychotic and Procognitive Properties.
1/2016	Novel 1H-Pyrrolo[3,2-c]quinoline Based 5-HT6 Receptor Antagonists with Potential Application for the Treatment of Cognitive Disorders Associated with Alzheimer's Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Grzegorz Satała Research Topics

Disease

9	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 01/2016
5	Cognitive Dysfunction 10/2021 - 01/2016
5	Memory Disorders (Memory Loss) 12/2020 - 01/2016
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023 - 01/2019
4	Schizophrenia (Dementia Praecox) 01/2021 - 02/2018
3	Mental Disorders (Mental Disorder) 09/2023 - 01/2018
3	Central Nervous System Diseases (CNS Diseases) 01/2022 - 11/2020
3	Seizures (Absence Seizure) 01/2018 - 01/2012
2	Psychotic Disorders (Schizoaffective Disorder) 11/2023 - 07/2021
2	Dementia (Dementias) 10/2021 - 01/2016
2	Neuralgia (Stump Neuralgia) 10/2021 - 05/2019
2	Epilepsy (Aura) 01/2018 - 01/2012
1	Anhedonia 09/2023
1	Frontotemporal Dementia (Semantic Dementia) 05/2023
1	Tauopathies 05/2023
1	Hyperalgesia 10/2021
1	Neoplasms (Cancer) 07/2021
1	Chronic Pain 12/2020
1	Cardiotoxicity 12/2020
1	Pain (Aches) 12/2020
1	Acute Pain 12/2020
1	Neurobehavioral Manifestations 01/2019
1	Hepatocellular Carcinoma (Hepatoma) 01/2018
1	Neuroblastoma 01/2018
1	Hypothermia 12/2016
1	Tics (Tic) 03/2015

Drug/Important Bio-Agent (IBA)

10	LigandsIBA 11/2023 - 01/2019
8	Serotonin (5 Hydroxytryptamine)IBA 11/2023 - 01/2012
4	Serotonin ReceptorsIBA 01/2024 - 01/2019
4	serotonin 6 receptorIBA 10/2021 - 01/2016
4	Scopolamine (Hyoscine)FDA Link 12/2020 - 01/2018
2	Dopamine (Intropin)FDA LinkGeneric 01/2023 - 01/2019
2	serotonin 7 receptorIBA 01/2022 - 05/2019
2	AminesIBA 10/2021 - 10/2019
2	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2021 - 01/2019
2	Glycogen Synthase Kinase 3IBA 01/2021 - 01/2019
2	Formaldehyde (Formol)FDA Link 12/2020 - 01/2018
2	Analgesics (Analgesic Drugs)IBA 05/2019 - 01/2018
2	quinolineIBA 01/2019 - 01/2016
2	Phencyclidine (Angel Dust)IBA 01/2018 - 01/2016
2	Pentylenetetrazole (Metrazol)IBA 01/2018 - 03/2016
2	3- benzenesulfonyl- 8- piperazin- 1- ylquinolineIBA 06/2016 - 01/2016
1	SeleniumIBA 01/2024
1	TriazinesIBA 11/2023
1	Ether (Diethyl Ether)IBA 11/2023
1	Hallucinogens (Psychedelics)IBA 09/2023
1	Psilocybin (Psilocibin)IBA 09/2023
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 05/2023
1	Amisulpride (Solian)IBA 05/2023
1	XanthineIBA 01/2023
1	Monoamine Oxidase (MAO)IBA 06/2022
1	Proteins (Proteins, Gene)FDA Link 10/2021
1	Phosphotransferases (Kinase)IBA 10/2021
1	Adenosine (Adenocard)FDA LinkGeneric 07/2021
1	CytokinesIBA 07/2021
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 07/2021
1	Ondansetron (Zofran)FDA LinkGeneric 01/2021
1	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 01/2021
1	5-HT1A Serotonin ReceptorIBA 01/2021
1	Opioid Analgesics (Opioids)IBA 12/2020
1	Lurasidone Hydrochloride FDA Link 01/2020
1	naphthaleneIBA 10/2019
1	Antipsychotic Agents (Antipsychotics)IBA 01/2019
1	gamma-Aminobutyric Acid (GABA)IBA 01/2019
1	Dopamine Agents (Dopaminergic Agents)IBA 01/2019
1	Dopamine D2 Receptor AntagonistsIBA 01/2019
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2019
1	Glutamic Acid (Glutamate)FDA Link 01/2019
1	Glycine Plasma Membrane Transport ProteinsIBA 01/2019
1	Dopamine D3 ReceptorsIBA 01/2019
1	pyrrolidineIBA 01/2019
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2019
1	Therapeutic UsesIBA 02/2018
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 02/2018
1	compound 17IBA 01/2018
1	Nootropic Agents (Nootropics)IBA 01/2018
1	Donepezil (Aricept)FDA LinkGeneric 01/2018
1	Cytochrome P-450 CYP3AIBA 01/2018
1	AutoreceptorsIBA 12/2016
1	8-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT)IBA 12/2016
1	AmidesIBA 03/2015

Therapy/Procedure

2	Therapeutics 09/2023 - 12/2020
2	Drug Therapy (Chemotherapy) 01/2020 - 01/2012
1	Ligation 10/2021